Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Molina Healthcare, Inc. (NYSE: MOH), a FORTUNE 500 company that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. These regulatory documents offer detailed insight into how Molina reports its operations, capital structure, and material events.
Among the key filings are Form 8-K current reports, where Molina discloses material developments. Recent 8-Ks describe the private offering of 6.500% Senior Notes due 2031, including interest terms, maturity, ranking, redemption features, and the related indenture. Other 8-Ks outline a new revolving credit facility, amendments to the company’s credit agreement, and a delayed draw term loan used to partially fund a stock repurchase program.
Additional 8-K filings furnish earnings releases for specific quarters, summarizing premium revenue, total revenue, net income, medical care costs, medical care ratios, and segment performance for Medicaid, Medicare, and marketplace operations. These reports also include reconciliations of non-GAAP measures such as adjusted net income, EBITDA, and Adjusted EBITDA, along with explanations of how these metrics are calculated and their limitations.
Investors can also review filings that discuss Medicaid and CHIP contract developments, such as the Notice of Agency Decision indicating an intent to award Molina Healthcare of Florida a Statewide Medicaid Managed Care and Children’s Health Insurance Program contract for the Children’s Medical Services Program. These documents help explain how new or renewed contracts may affect membership and premium revenue.
On Stock Titan, Molina Healthcare’s filings are updated as they are released on EDGAR, and AI-powered summaries highlight the main terms, financial impacts, and segment implications of each document. This allows users to quickly understand complex credit agreements, debt offerings, and earnings disclosures without reading every page of the underlying filing.
Molina Healthcare director Ronna Romney, through the Ronna Romney Revocable Trust, reported an open-market sale of 506 shares of Common Stock on March 12, 2026. The shares were sold at a volume-weighted average price of $146.92 per share, with individual trade prices ranging from $146.80 to $147.10.
Following this transaction, the trust continues to hold 17,227 Molina Healthcare shares indirectly attributed to Romney. The sale represents a relatively small portion of the trust’s overall reported holdings and appears as a routine portfolio adjustment rather than a large position change.
Molina Healthcare, Inc. is soliciting proxies for its 2026 Annual Meeting to be held virtually on
The proxy asks stockholders to: elect ten directors; approve an advisory say-on-pay vote for 2025 executive compensation; ratify Ernst & Young LLP as auditor for 2026; approve an amendment to the 2025 Equity Incentive Plan to increase shares available; and amend the Certificate of Incorporation to permit stockholders to call special meetings. The company reports serving approximately 5.5 million members as of
Filer: Fidelity Brokerage Services LLC filed a Form 144 reporting an intended sale of Common stock related to holdings on the NYSE.
The filing lists transaction identifiers including 506, 74220.08, and 51500000, and references 03/11/2026. The entries show prior stock awards dated 04/05/2023 (206 shares) and 01/02/2014 (300 shares).
Molina Healthcare President & CEO Joseph M. Zubretsky reported equity compensation transactions in company common stock. On March 1, 2026, 8,597 shares were disposed of at
On the same date, he received a grant of 66,417 restricted shares at a reference price of
After these transactions, he directly owned 99,015 shares and indirectly held 257,715 shares through the Joseph M. Zubretsky Revocable Trust, where he serves as sole trustee.
Molina Healthcare’s Chief Financial Officer Mark Lowell Keim reported equity compensation activity involving the company’s common stock. On March 1, 2026, he received a grant of 26,073 restricted shares under the 2025 Equity Incentive Plan at a reference price of $145.75 per share, based on a 10‑day VWAP. On the same date, 2,308 shares valued at $154.05 per share were withheld to cover taxes tied to the vesting of 6,563 shares, rather than sold on the open market. After these transactions, he directly held 83,251 shares of Molina Healthcare common stock. The new grant vests in one‑third increments on March 1, 2027, March 1, 2028, and March 1, 2029, with additional scheduled vesting of 4,613 shares on March 1, 2027 and 2,892 shares on March 1, 2028.
Molina Healthcare Chief Operating Officer James Woys reported two equity-related transactions in company common stock. On March 1, 2026, 1,313 shares were disposed of to cover withholding taxes triggered by the vesting of 5,337 shares, using a price of $154.05 per share, leaving 73,018 shares directly held after this step.
On the same date, he received a grant of 17,016 restricted shares under the 2025 Equity Incentive Plan at $145.75 per share, based on a volume-weighted average price for the 10 trading days before March 1, 2026. These 17,016 shares vest in three equal installments on March 1, 2027, 2028, and 2029. Additional unvested tranches include 3,632 shares vesting on March 1, 2027 and 2,082 shares on March 1, 2028. After the grant, he directly held 90,034 shares.
Molina Healthcare Chief Accounting Officer Maurice Hebert reported a mix of stock awards and tax-related share withholdings. On March 1, 2026, he received 650 shares of common stock issued in settlement of performance stock units granted on March 1, 2023, based on three-year average adjusted earnings per share at an 89% vesting level. The company also withheld 229 shares and 272 shares, at a price of $154.05, to cover tax liabilities tied to these vestings. In a separate transaction on the same date, Hebert received a grant of 2,058 restricted shares under the 2025 Equity Incentive Plan at a reference price of $145.75, which will vest in stages through March 1, 2029. After these transactions, he directly owned 11,357 shares of Molina Healthcare common stock.
Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow reported equity compensation changes on
On the same date, 1,638 shares were withheld at
Molina Healthcare executive Debra Bacon reported equity compensation activity and related tax withholding. On March 1, 2026, 716 shares of common stock at
On the same date, Bacon received a grant of 9,606 restricted shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan at a reference price of
Molina Healthcare reaffirmed its 2026 full-year earnings outlook ahead of upcoming investor meetings and a health care conference appearance. Management continues to expect at least $3.20 in GAAP diluted EPS and at least $5.00 in adjusted diluted EPS for 2026.
The company will present at TD Cowen’s 46th Annual Health Care Conference on March 3, 2026, with a live webcast and 30‑day replay on its investor relations website. Molina also set dates for its first-quarter 2026 earnings release and call on April 22–23, 2026, and announced an Investor Day on May 8, 2026, both with live webcasts and 30‑day replays.